Stay updated on Flutiform K-haler Clinical Trial

Sign up to get notified when there's something new on the Flutiform K-haler Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Flutiform K-haler Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T21:29:01.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the efficacy evaluation of Flutiform K-haler after 12 weeks of treatment in patients with moderate to severe uncontrolled asthma following mid-dose ICS/LABA DPI therapy.
    Difference
    0.1%
    Check dated 2024-06-06T14:27:13.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for the study, specifying that researchers are looking for Korean asthma patients aged 19 years or older with moderate to severe persistent asthma, as defined by the GINA 2018 guideline, and a history of ICS/LABA DPI use. Previously, no specific information was provided in this section.
    Difference
    20%
    Check dated 2024-05-22T21:10:00.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:28:51.000Z thumbnail image

Stay in the know with updates to Flutiform K-haler Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Flutiform K-haler Clinical Trial page.